Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LOXO

Loxo Oncology (LOXO) Stock Price, News & Analysis

Loxo Oncology logo

About Loxo Oncology Stock (NASDAQ:LOXO)

Advanced Chart

Key Stats

Today's Range
$234.66
$234.66
50-Day Range
N/A
52-Week Range
$101.70
$234.93
Volume
400 shs
Average Volume
565,561 shs
Market Capitalization
$7.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LOXO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Loxo Oncology and its competitors with MarketBeat's FREE daily newsletter.

LOXO Stock News Headlines

[Warning] Buffett Indicator hits new All-Time-High
Warren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullish for stocks. In fact, the last three times this happened, a major market pullback followed… and gold entered a decade-long bull run. If history’s any guide, the smartest move today could be positioning in gold—specifically, a handful of high-potential developers.
Q3 2024 Eli Lilly and Co Earnings Call
See More Headlines

LOXO Stock Analysis - Frequently Asked Questions

Loxo Oncology Inc (NASDAQ:LOXO) issued its quarterly earnings results on Thursday, August, 9th. The biopharmaceutical company reported ($0.39) EPS for the quarter, topping the consensus estimate of ($0.54) by $0.15. The biopharmaceutical company had revenue of $42.60 million for the quarter, compared to analysts' expectations of $32.36 million. Loxo Oncology had a negative net margin of 43.49% and a negative trailing twelve-month return on equity of 16.42%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Loxo Oncology investors own include Meta Platforms (META), Bristol Myers Squibb (BMY), NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), GW Pharmaceuticals (GWPH) and Micron Technology (MU).

Company Calendar

Last Earnings
8/09/2018
Today
8/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LOXO
CIK
1581720
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($5.31)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$148.87 million
Net Margins
-43.49%
Pretax Margin
N/A
Return on Equity
-16.42%
Return on Assets
-8.66%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.62
Quick Ratio
3.62

Sales & Book Value

Annual Sales
$21.30 million
Price / Sales
337.23
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$12.63 per share
Price / Book
18.58

Miscellaneous

Outstanding Shares
30,610,000
Free Float
N/A
Market Cap
$7.18 billion
Optionable
Optionable
Beta
2.51
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:LOXO) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners